Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Research data is the primary deliverable of the MDC and it is essential to have an evident and secure way of its documentation. The data will be used to advance internal capability-build and external feefor-service research projects from a diverse set of scientific technologies, including Mass
Spectrometry, Imaging, In-vivo Imaging, Complex Cells, Biomarker and Target Engagement &
Validation studies. Consistent with MDC's vision of collaborative working, the platform must enable seamless data sharing of refined data for internal and external projects with scientists and institutions.
The software's main task is to document analysed research data and to provide evidence of Good
Laboratory Practice as well as improving lab productivity and efficiency, by keeping track of data associated with samples, experiments, laboratory workflows, and instruments. MDC does not currently have a commercial ELN as the previous ELN contract ended in July 2021.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Collaborative Drug Discovery, Inc. | - | £165,000 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £165,000 initial term | Collaborative Drug Discovery, Inc. | active |